ОТНОСТНО ТОЗИ ЕПИЗОД

Английски
САЩ

ТРАНСКРИПЦИЯ 🔗

ТЪРСЕНЕ на МИНАЛИ ЕПИЗОДИ

Търсене в минали епизоди на Longevity.Technology UNLOCKED.

ДРУГИ ЕПИЗОДИ В ТОЗИ ПОДКАСТ

Guests: Paola Telfer Founder and CEO of Sens.ai LinkedIn: www.linkedin.com/in/paolatelfer/ Website: sens.ai/ Eric Verdin, MD President and CEO of the Buck Institute for Research on Aging LinkedIn: www.linkedin.com/in/eric-verdin-md/ Website: www.buckinstitute.org/ ---------- What if we could tr…
Guest: Joanna Bensz Founder & CEO of Longevity Center and Longevity Academy LinkedIn: https://www.linkedin.com/in/joanna-bensz-205b315/ Website: https://longevity-academy.com/, https://longevity-center.eu/ ---------- What happens when longevity becomes a global industry before the medical sys…
In this week’s Longevity News Roundup, Phil Newman examines the developments reshaping longevity and healthspan, from a major biotech investment in hair loss to AI-driven drug repurposing, the industry’s communication challenge, biological-age testing at population scale, and the push to manufactur…

Will AI Make Death Optional?

What would have to be true for AI to genuinely change the trajectory of human aging? The answer is more complicated than simply discovering an “anti-aging drug.” AI is already compressing parts of drug discovery, with one AI-designed candidate reaching Phase 2 trials in under 30 months, while new …
In this week’s Longevity News Roundup, Phil Newman examines Oura’s IPO and sleep suit, movement context in dementia, dog gene therapy, Rentosertib biological clocks, and women's health. ŌURA filed for a $16 billion IPO on Nasdaq under ticker Oura, seeking to raise up to $3 billion. Simultaneously…
Опровержение: Подкастът и произведенията на изкуството, вградени на тази страница, са от Longevity.Technology, което е собственост на неговия собственик и не е свързано с или одобрено от Listen Notes, Inc.